In this case I analyze the financing plan of Purinex Inc.. I need to determine what the best financial alternative is for the company to start a partnership with a major pharmaceutical company. Purinex believes there is an opportunity to partner with a major company within the next four to 12 months. There's one big problem though. Purinex has funds that will only last about eleven months. Purinex's chief financial officer believes that if a partnership is realized, the deal could lead the company to realize its main goal, which is to develop drugs for the diseases sepsis and diabetes. Purinex faces the challenge of lack of money if a partnership is not reached in time. To address this challenge, Harpaz is faced with three options that could solve the problem. In the following paper I discuss the situation followed by an analysis of each of the three options “venture capital round option”, “wait six months option” and “angel round option”. Lastly, I recommend it be the “angel ride option”. I decided to go with the round angel option for a couple of reasons. I believe it is the safest option of the three and gives Purinex the best opportunity to partner with a large company before losing valuation within the company. Plus, there aren't as many restrictions and the $2 million from angel investors gives the company a little more leeway. Additionally, taking this approach carries far less risk. Situational Analysis: Purinex is a pharmaceutical drug research and development company that wanted to commercialize curative compounds based on its purine-based drug development platform. The company consisted of 14 employees and a chemical laboratory. Also, Purinex had an intellect… middle of paper… options, the angel round option seems to be the best. The angel investor deal would take 6 months to get the capital injection needed to sustain operations until a partnership deal is concluded. I believe this is a good option because there is a 95% chance of forming a partnership within the next two years. With this $2 million injection Purinex will be able to survive until the deal closes. Furthermore, I believe that the angel round option is the better alternative because the company's valuation will be much higher than the venture capital round option. Additionally, there are not as many controls or restrictions compared to the venture capital round option. I think this is better than the "wait six months" option because I think the "wait six months" option is too risky. Receiving just $2 million from angel investors gives Purinex a little more leeway.